Hosted on MSN19d
LifeSci Capital Initiates Coverage of Immunome (IMNM) with Outperform Recommendation
Fintel reports that on March 11, 2025, LifeSci Capital initiated coverage of Immunome (NasdaqCM:IMNM) with a Outperform recommendation. Analyst Price Forecast Suggests 250.92% Upside As of March 4 ...
ETF Daily News3d
Immunome (NASDAQ:IMNM) Shares Gap Up After Insider Buying Activity
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) shares gapped up prior to trading on Wednesday following insider buying activity. The stock had previously closed at $6.95, but opened at $7.44.